{"id":"https://openalex.org/W4402555068","doi":"https://doi.org/10.1093/nop/npae037","title":"Disease burden and healthcare utilization in pediatric low-grade glioma: A United States retrospective study of linked claims and electronic health records","display_name":"Disease burden and healthcare utilization in pediatric low-grade glioma: A United States retrospective study of linked claims and electronic health records","publication_year":2024,"publication_date":"2024-04-27","ids":{"openalex":"https://openalex.org/W4402555068","doi":"https://doi.org/10.1093/nop/npae037","pmid":"https://pubmed.ncbi.nlm.nih.gov/39279771","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11398936"},"language":"en","primary_location":{"id":"doi:10.1093/nop/npae037","doi":"https://doi.org/10.1093/nop/npae037","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nop/npae037","pdf_url":null,"source":{"id":"https://openalex.org/S2735333031","display_name":"Neuro-Oncology Practice","issn_l":"2054-2577","issn":["2054-2577","2054-2585"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1093/nop/npae037","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078082343","display_name":"Susan Zelt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264990","display_name":"Day One Biopharmaceuticals (United States)","ror":"https://ror.org/03hz16t86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264990"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Zelt","raw_affiliation_strings":["Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)","institution_ids":["https://openalex.org/I4405264990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072705088","display_name":"Tabitha M. Cooney","orcid":"https://orcid.org/0000-0002-1178-0132","observed_orcids":["https://orcid.org/0000-0002-1178-0132","https://orcid.org/0000-0002-2614-020X"]},"institutions":[{"id":"https://openalex.org/I4405264990","display_name":"Day One Biopharmaceuticals (United States)","ror":"https://ror.org/03hz16t86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264990"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tabitha Cooney","raw_affiliation_strings":["Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)","institution_ids":["https://openalex.org/I4405264990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110985537","display_name":"Sandie Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264990","display_name":"Day One Biopharmaceuticals (United States)","ror":"https://ror.org/03hz16t86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264990"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandie Yu","raw_affiliation_strings":["Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)","institution_ids":["https://openalex.org/I4405264990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053868020","display_name":"Shailaja Daral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shailaja Daral","raw_affiliation_strings":["Optum Lifesciences, Inc. , Eden Prairie, Minnesota, USA (S.D., B.K., R.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum Lifesciences, Inc. , Eden Prairie, Minnesota, USA (S.D., B.K., R.M.)","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087222966","display_name":"Blake Krebs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Blake Krebs","raw_affiliation_strings":["Optum Lifesciences, Inc. , Eden Prairie, Minnesota, USA (S.D., B.K., R.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum Lifesciences, Inc. , Eden Prairie, Minnesota, USA (S.D., B.K., R.M.)","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000892549","display_name":"Riddhi Kumar Markan","orcid":"https://orcid.org/0000-0001-6834-318X","observed_orcids":["https://orcid.org/0000-0001-6834-318X"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riddhi Markan","raw_affiliation_strings":["Optum Lifesciences, Inc. , Eden Prairie, Minnesota, USA (S.D., B.K., R.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum Lifesciences, Inc. , Eden Prairie, Minnesota, USA (S.D., B.K., R.M.)","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030335484","display_name":"Peter E. Manley","orcid":"https://orcid.org/0000-0003-3485-4517","observed_orcids":["https://orcid.org/0000-0003-3485-4517"]},"institutions":[{"id":"https://openalex.org/I4405264990","display_name":"Day One Biopharmaceuticals (United States)","ror":"https://ror.org/03hz16t86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264990"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Manley","raw_affiliation_strings":["Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)","institution_ids":["https://openalex.org/I4405264990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060208068","display_name":"Mark W. Kieran","orcid":"https://orcid.org/0000-0003-2184-7692","observed_orcids":["https://orcid.org/0000-0003-2184-7692"]},"institutions":[{"id":"https://openalex.org/I4405264990","display_name":"Day One Biopharmaceuticals (United States)","ror":"https://ror.org/03hz16t86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264990"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Kieran","raw_affiliation_strings":["Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)","institution_ids":["https://openalex.org/I4405264990"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109314594","display_name":"Sandya Govinda Raju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264990","display_name":"Day One Biopharmaceuticals (United States)","ror":"https://ror.org/03hz16t86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264990"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sandya Govinda Raju","raw_affiliation_strings":["Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Day One Biopharmaceuticals, Inc. , Brisbane, California , USA (S.Z., T.C., S.Y., P.M., M.K., S.G.R.)","institution_ids":["https://openalex.org/I4405264990"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109314594"],"corresponding_institution_ids":["https://openalex.org/I4405264990"],"apc_list":{"value":5288,"currency":"USD","value_usd":5288},"apc_paid":{"value":5288,"currency":"USD","value_usd":5288},"fwci":1.683,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.83385662,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":98},"biblio":{"volume":"11","issue":"5","first_page":"583","last_page":"592"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11141","display_name":"Childhood Cancer Survivors' Quality of Life","score":0.06480000168085098,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-low-grade-glioma","display_name":"pediatric low-grade glioma","score":1.0},{"id":"https://openalex.org/keywords/disease-burden","display_name":"disease burden","score":0.9760000109672546},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.9240000247955322},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8700000047683716},{"id":"https://openalex.org/keywords/long-term-health-effects","display_name":"long-term health effects","score":0.703000009059906},{"id":"https://openalex.org/keywords/seizures","display_name":"seizures","score":0.5049999952316284},{"id":"https://openalex.org/keywords/visual-impairment","display_name":"visual impairment","score":0.6129999756813049},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.6589999794960022},{"id":"https://openalex.org/keywords/antiemetics","display_name":"antiemetics","score":0.6190000176429749},{"id":"https://openalex.org/keywords/anti-infective-therapy","display_name":"anti-infective therapy","score":0.5820000171661377},{"id":"https://openalex.org/keywords/brain-surgery","display_name":"brain surgery","score":0.5080000162124634},{"id":"https://openalex.org/keywords/pediatric-brain-tumors","display_name":"pediatric brain tumors","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8811279535293579},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6414613723754883},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5350291728973389},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.5344931483268738},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5028800368309021},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4919745624065399},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.4819300174713135},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.46380141377449036},{"id":"https://openalex.org/C45827449","wikidata":"https://www.wikidata.org/wiki/Q5270338","display_name":"Diagnosis code","level":3,"score":0.45181918144226074},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4272868037223816},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.42636942863464355},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.4171752333641052},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17961937189102173},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.1682688295841217},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.09916964173316956},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/nop/npae037","doi":"https://doi.org/10.1093/nop/npae037","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nop/npae037","pdf_url":null,"source":{"id":"https://openalex.org/S2735333031","display_name":"Neuro-Oncology Practice","issn_l":"2054-2577","issn":["2054-2577","2054-2585"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology Practice","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11398936","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11398936","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11398936/pdf/npae037.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurooncol Pract","raw_type":"Text"},{"id":"pmid:39279771","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39279771","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-oncology practice","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/nop/npae037","doi":"https://doi.org/10.1093/nop/npae037","is_oa":true,"landing_page_url":"https://doi.org/10.1093/nop/npae037","pdf_url":null,"source":{"id":"https://openalex.org/S2735333031","display_name":"Neuro-Oncology Practice","issn_l":"2054-2577","issn":["2054-2577","2054-2585"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1781870113","https://openalex.org/W2021448795","https://openalex.org/W2050513151","https://openalex.org/W2051426927","https://openalex.org/W2054975328","https://openalex.org/W2086249929","https://openalex.org/W2100130667","https://openalex.org/W2110529088","https://openalex.org/W2112657281","https://openalex.org/W2119449786","https://openalex.org/W2124960242","https://openalex.org/W2129882467","https://openalex.org/W2591910005","https://openalex.org/W2612721230","https://openalex.org/W2652551831","https://openalex.org/W2791994751","https://openalex.org/W2904428669","https://openalex.org/W2905305816","https://openalex.org/W2909818488","https://openalex.org/W2930687275","https://openalex.org/W2952637776","https://openalex.org/W2968899582","https://openalex.org/W2983781124","https://openalex.org/W3005639301","https://openalex.org/W3008562187","https://openalex.org/W3010860768","https://openalex.org/W3022119017","https://openalex.org/W3028314233","https://openalex.org/W3047782867","https://openalex.org/W3174246647","https://openalex.org/W4211118794","https://openalex.org/W4214668334","https://openalex.org/W4220981780","https://openalex.org/W4282054061","https://openalex.org/W4283748425","https://openalex.org/W4294354723","https://openalex.org/W4294771429","https://openalex.org/W4309028333","https://openalex.org/W4310022963","https://openalex.org/W4311282539","https://openalex.org/W4312195338","https://openalex.org/W4365138871","https://openalex.org/W4366401370","https://openalex.org/W4367555374","https://openalex.org/W4380358959","https://openalex.org/W4381597651","https://openalex.org/W4386046933","https://openalex.org/W4386263948","https://openalex.org/W4392355409"],"related_works":["https://openalex.org/W4379280821","https://openalex.org/W7165795707","https://openalex.org/W2909818488","https://openalex.org/W4388551842","https://openalex.org/W4380358959","https://openalex.org/W1840085060","https://openalex.org/W2809505441","https://openalex.org/W4414503099","https://openalex.org/W2015730166","https://openalex.org/W2100130667"],"abstract_inverted_index":{"Background:":[0],"Despite":[1],"high":[2,228],"long-term":[3,161],"survival":[4],"rates,":[5],"pediatric":[6],"low-grade":[7],"gliomas":[8],"(pLGGs)":[9],"are":[10],"linked":[11],"with":[12,41,68,79,116,221],"significant":[13],"tumor-":[14],"and":[15,43,51,78,88,98,111,118,146,151,171,185,244,247],"treatment-associated":[16],"morbidities":[17],"that":[18],"may":[19],"persist":[20],"throughout":[21],"life.":[22],"The":[23,134],"aims":[24],"of":[25,39,47,81,177,194],"this":[26],"descriptive":[27],"cross-sectional":[28],"pilot":[29],"study":[30,132,158,217],"were":[31,60,100,114,138],"to":[32,62,198,237,241],"characterize":[33],"health":[34,94,143,162],"conditions":[35],"among":[36],"a":[37,232],"cohort":[38],"patients":[40,64,113,178,195],"pLGG":[42,82,117,222],"explore":[44],"the":[45,130,157,202,216],"feasibility":[46],"quantifying":[48],"disease":[49],"burden":[50,246],"healthcare":[52,225],"resource":[53],"utilization":[54],"(HRU).":[55],"Methods:":[56],"Market":[57],"Clarity":[58],"Data":[59],"used":[61],"identify":[63],"aged":[65],"\u226418":[66],"years":[67],"an":[69],"ICD-10":[70],"code":[71],"for":[72,181],"brain":[73,206],"neoplasm,":[74],"\u22651":[75],"physician":[76],"notes,":[77],"evidence":[80],"recorded":[83],"between":[84],"January":[85],"1,":[86],"2017":[87],"June":[89],"30,":[90],"2018.":[91],"Outcomes":[92],"including":[93,165],"characteristics,":[95],"HRU,":[96,164,229],"medications,":[97,173],"procedures":[99],"assessed":[101],"at":[102],"6-month":[103],"intervals":[104],"over":[105,119,231],"36":[106],"months.":[107],"Results:":[108],"One":[109],"hundred":[110],"fifty-four":[112],"identified":[115],"half":[120],"experienced":[121],"headache/migraine,":[122],"respiratory":[123],"infection,":[124],"pain,":[125],"or":[126,154,189],"behavioral":[127],"issues":[128],"during":[129,156,215],"36-month":[131],"period.":[133,218],"most":[135,203],"common":[136,204],"comorbidities":[137,152],"ocular/visual":[139],"(including":[140],"blindness),":[141],"mental":[142],"disorders,":[144],"seizures,":[145],"behavioral/cognition":[147],"disorders.":[148],"Most":[149],"symptoms":[150],"persisted":[153],"increased":[155],"period,":[159],"indicating":[160],"deficits.":[163],"speciality":[166],"care":[167],"visits,":[168],"filled":[169],"prescriptions,":[170],"administered":[172],"was":[174,210],"common;":[175],"74%":[176],"had":[179],"prescriptions":[180],"anti-infectives,":[182],"56%":[183],"antiemetics,":[184],"52%":[186],"required":[187],"pain":[188],"fever":[190],"relief.":[191],"Sixty-five":[192],"percent":[193],"underwent":[196],"treatment":[197],"control":[199],"their":[200],"pLGG,":[201],"being":[205],"surgery.":[207],"Little":[208],"decline":[209],"observed":[211],"in":[212],"medication":[213],"use":[214],"Conclusions:":[219],"Patients":[220,235],"have":[223],"complex":[224],"needs":[226],"requiring":[227],"often":[230],"long":[233],"time.":[234],"need":[236],"be":[238],"optimally":[239],"managed":[240],"minimize":[242],"disease-":[243],"treatment-related":[245],"HRU.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-09-17T00:00:00"}